Assoc QC Analyst
Regeneron Pharmaceuticals
Summary
Summary: Performs a variety of chemical or biological analyses on raw materials, products, in-process materials, or stability samples in support of the company's quality program.
Job description
Essential Duties and Responsibilities
- Gathers data and documents test results.
- Reviews test results to ensure compliance with standards; reports any quality anomalies.
- Complies with all pertinent regulatory agency requirements.
- Participates in required training activities.
- Maintains laboratory supplies.
- Conducts testing on raw materials, in-process, product, stability, and/or research samples.
- Writes and revises control test procedures and SOPs.
- Completes test records and reviews data.
- Calibrates or verifies calibration of instruments/devices prior to use.
- Interacts with outside customers or functional peer groups.
- May be responsible for maintaining a specific project.
- May devise or develop new analytical methods and techniques.
- May assist in validation of methods.
- May be involved in establishing the transfer of methodology from R&D.
Education and Experience
Requires BS/BA in Life Sciences or related field; will substitute relevant experience for education.
Requirements
- BS/BA in Life Sciences or related field (relevant experience may substitute)
- Ability to perform chemical or biological analyses on raw materials, products, in-process materials, or stability samples
- Ability to document test results and review data for compliance with standards
- Knowledge of regulatory agency requirements
- Ability to write and revise control test procedures and SOPs
- Ability to calibrate or verify calibration of instruments/devices
Benefits
- Annual Bonuses
- Incentive Plans
- Equity Awards
- Pension/Retirement Benefits
- 401(k) Matching
- Health & Wellness Programs
- Fitness Centers
- Medical, Dental & Vision
- Life & Disability Insurance
- Paid Time Off
- Family Support Benefits
Company overview
Regeneron Pharmaceuticals is a leading American biotechnology company founded in 1988 and headquartered in Tarrytown, New York. The company specializes in inventing, developing, and commercializing life-transforming medicines for people with serious diseases. Regeneron is renowned for its innovative antibody technologies and has developed several groundbreaking therapies, including EYLEA® for retinal diseases, DUPIXENT® for inflammatory conditions, and the COVID-19 antibody cocktail REGEN-COV®. The company operates with a strong focus on research and development across multiple therapeutic areas including ophthalmology, oncology, cardiovascular diseases, and rare genetic disorders. Regeneron's proprietary VelocImmune® technology platform enables the rapid generation of fully human monoclonal antibodies. With over 15,000 employees globally and annual revenues exceeding $14 billion, Regeneron has established itself as a major force in the biotechnology industry, consistently ranking among the top-performing pharmaceutical companies and maintaining a robust pipeline of investigational therapies.